INTELLIGENT BIO SOLUTIONS INC. Convertible Notes Payable
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Convertible Notes Payable of $389.36 thousand as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Debt › Notes and Loans Payable
us-gaap:ConvertibleNotesPayable · last filed 2023-05-11
- 2023-03-31: Convertible Notes Payable $389.36K.
- 2022-12-31: Convertible Notes Payable $523.70K.
| Period end | Convertible Notes Payable |
|---|---|
| 2023-03-31 | $389.36K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $523.70K 10-Q · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |